X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
oncology (9) 9
index medicus (7) 7
adult (6) 6
female (6) 6
adenocarcinoma - genetics (5) 5
animals (5) 5
cancer (5) 5
lung neoplasms - genetics (5) 5
male (5) 5
adenocarcinoma - pathology (4) 4
aged (4) 4
cell line, tumor (4) 4
lung neoplasms - pathology (4) 4
middle aged (4) 4
mutation - genetics (4) 4
pathology (4) 4
polymerase chain reaction (4) 4
activation (3) 3
adenocarcinoma (3) 3
blotting, western (3) 3
cajal (3) 3
cell proliferation (3) 3
dna, neoplasm - analysis (3) 3
epithelial-mesenchymal transition (3) 3
expression (3) 3
growth-factor-receptor (3) 3
interstitial-cells (3) 3
lung cancer (3) 3
lung neoplasms - drug therapy (3) 3
lung neoplasms - metabolism (3) 3
mice (3) 3
mice, scid (3) 3
mutation (3) 3
mutations (3) 3
oligonucleotide array sequence analysis (3) 3
proto-oncogene proteins c-kit - genetics (3) 3
proto-oncogene proteins c-met - genetics (3) 3
proto-oncogene proteins c-met - metabolism (3) 3
adenocarcinoma - drug therapy (2) 2
adenocarcinoma - metabolism (2) 2
adenocarcinoma of lung (2) 2
analysis (2) 2
antineoplastic agents - pharmacology (2) 2
apoptosis (2) 2
biomarkers, tumor - metabolism (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, squamous cell - pathology (2) 2
carcinomas (2) 2
cloning (2) 2
development and progression (2) 2
domain mutations (2) 2
erbb receptors - genetics (2) 2
gastrointestinal stromal tumors (2) 2
gene amplification (2) 2
gene expression profiling (2) 2
genetic aspects (2) 2
human mastocytosis (2) 2
immunoenzyme techniques (2) 2
immunohistochemistry (2) 2
lung adenocarcinoma (2) 2
met (2) 2
metastasis (2) 2
mice, inbred nod (2) 2
neoplasm metastasis - pathology (2) 2
of-function mutation (2) 2
phenotype (2) 2
phosphorylation - drug effects (2) 2
polymorphism, single nucleotide (2) 2
prognosis (2) 2
protein kinase inhibitors - pharmacology (2) 2
proto-oncogene proteins - genetics (2) 2
proto-oncogene proteins - metabolism (2) 2
proto-oncogene proteins c-kit - metabolism (2) 2
proto-oncogene proteins p21 (2) 2
protooncogene (2) 2
ras proteins - genetics (2) 2
ras proteins - metabolism (2) 2
receptor, epidermal growth factor - genetics (2) 2
receptor, epidermal growth factor - metabolism (2) 2
research (2) 2
resistance (2) 2
respiratory system (2) 2
reverse transcriptase polymerase chain reaction (2) 2
tumor cells, cultured (2) 2
tumors (2) 2
a549 cells (1) 1
abridged index medicus (1) 1
acetylcysteine - analogs & derivatives (1) 1
acetylcysteine - pharmacology (1) 1
acquired resistance (1) 1
actins - analysis (1) 1
actins - metabolism (1) 1
adenocarcinoma - classification (1) 1
adenocarcinoma - enzymology (1) 1
adenocarcinoma - physiopathology (1) 1
adenocarcinoma - secondary (1) 1
adenocarcinoma - ultrastructure (1) 1
adenocarcinomas (1) 1
adhesion (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0181342
Decreased cell-substratum adhesion is crucially involved in metastasis. Previous studies demonstrated that lung cancer with floating cell clusters in histology... 
EPITHELIAL-MESENCHYMAL TRANSITION | IMPACT | INHIBITION | ZEB1 | GENE | ADENOCARCINOMA | MULTIDISCIPLINARY SCIENCES | HISTOLOGIC SUBTYPE | RESISTANCE | E-CADHERIN | EMT | Neoplasm Transplantation | Adenocarcinoma - pathology | Cell Proliferation | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Spheroids, Cellular - pathology | Lung Neoplasms - pathology | Genes, myc | Lung Neoplasms - physiopathology | Zinc Finger E-box-Binding Homeobox 1 - genetics | Zinc Finger E-box-Binding Homeobox 1 - metabolism | Cell Line, Tumor - pathology | Adenocarcinoma - physiopathology | Cell Line, Tumor - physiology | Female | Adenocarcinoma - genetics | Lung Neoplasms - genetics | A549 Cells | Cell Culture Techniques - instrumentation | Organic Cation Transport Proteins - metabolism | Mice, SCID | Cell Adhesion | Adenocarcinoma - secondary | Neoplasm Metastasis - genetics | Animals | Neoplasm Metastasis - pathology | Neoplasm Metastasis - physiopathology | Mice, Inbred NOD | Apoptosis - physiology | Mutation | Cell Movement | Cell culture | Research | Metastasis | Lung cancer | Cancer cells | Adenocarcinoma | Biotechnology | Thoracic surgery | Leukocyte migration | Mesenchyme | Cytology | c-Myc protein | Myc protein | K-Ras protein | Metastases | Cell growth | Histopathology | Surgery | Cell cycle | Immunoglobulins | Genomic analysis | Cultures | Pharmacology | Histology | Injection | Tumor cell lines | Adhesion | Spheroids | Amplification | Pathology | Gene amplification | Medical prognosis | Mice | In vitro methods and tests | Cell migration | Cancer
Journal Article
Laboratory Investigation, ISSN 0023-6837, 10/2013, Volume 93, Issue 10, pp. 1137 - 1146
Lung cancers harboring epidermal growth factor receptor (EGFR) mutations depend on constitutive activation of the kinase for survival. Although most... 
EGFR mutation | autophagy | epithelial-to-mesenchymal transition (EMT) | acquired resistance | lung adenocarcinoma | TARGETED THERAPY | MEDICINE, RESEARCH & EXPERIMENTAL | APOPTOSIS | STEM-CELLS | GROWTH-FACTOR-RECEPTOR | KINASE INHIBITOR | PATHOLOGY | HYPOXIA | CANCER | RESISTANCE | MUTATIONS | MET | Lung Neoplasms - drug therapy | Adenocarcinoma - ultrastructure | Adenocarcinoma of Lung | Microtubule-Associated Proteins - genetics | Microtubule-Associated Proteins - metabolism | Humans | Lung Neoplasms - metabolism | ErbB Receptors - genetics | Drug Resistance, Neoplasm | Male | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - metabolism | Autophagy - drug effects | Adenocarcinoma - metabolism | RNA Interference | Epithelial-Mesenchymal Transition | Adult | Female | Phagosomes - ultrastructure | Adenocarcinoma - genetics | Antineoplastic Agents - pharmacology | Lung - metabolism | Neoplasm Proteins - genetics | Mutant Proteins - antagonists & inhibitors | Phagosomes - drug effects | Lung Neoplasms - genetics | Cell Hypoxia - drug effects | Lung - pathology | ErbB Receptors - antagonists & inhibitors | ErbB Receptors - metabolism | Cell Survival | Phagosomes - metabolism | Mutant Proteins - metabolism | Microtubule-Associated Proteins - antagonists & inhibitors | Adenocarcinoma - drug therapy | Autophagy-Related Protein 5 | Lung - drug effects | Lung Neoplasms - ultrastructure | Cell Line, Tumor | Aged | Protein Kinase Inhibitors - pharmacology
Journal Article
Cancer Science, ISSN 1347-9032, 01/2008, Volume 99, Issue 1, pp. 14 - 22
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 12/2012, Volume 7, Issue 12, pp. 1872 - 1876
Journal Article
Cancer Science, ISSN 1347-9032, 09/2004, Volume 95, Issue 9, pp. 716 - 720
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 09/2010, Volume 5, Issue 9, pp. 1317 - 1324
No comprehensive data are available on the molecular predictors of sensitivity to MET inhibitor in lung carcinomas. We examined the efficacy of the MET... 
PHA665752 | MET | Lung cancer | EGFR | CANCER PATIENTS | ACTIVATION | GROWTH-FACTOR-RECEPTOR | ADENOCARCINOMAS | PHA-665752 | TYROSINE KINASE INHIBITORS | IN-VITRO | ONCOLOGY | RESPIRATORY SYSTEM | C-MET | GENE AMPLIFICATION | MUTATIONS | Proto-Oncogene Proteins c-met - metabolism | Lung Neoplasms - drug therapy | Predictive Value of Tests | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Cell Proliferation | Oligonucleotide Array Sequence Analysis | Humans | Lung Neoplasms - metabolism | Receptors, Growth Factor - antagonists & inhibitors | ras Proteins - metabolism | Carcinoma, Non-Small-Cell Lung - diagnosis | Gene Expression Profiling | Sulfones - pharmacology | Receptors, Growth Factor - genetics | Receptor, Epidermal Growth Factor - metabolism | Epithelial-Mesenchymal Transition | Polymerase Chain Reaction | Biomarkers, Tumor - metabolism | Indoles - pharmacology | Phosphorylation - drug effects | Tumor Cells, Cultured | Proto-Oncogene Proteins - metabolism | Signal Transduction | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - metabolism | Proto-Oncogene Proteins - genetics | Mutation - genetics | Blotting, Western | Proto-Oncogene Proteins c-met - genetics | Gene Amplification | Polymorphism, Single Nucleotide - genetics | Biomarkers, Tumor - genetics | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Drug Resistance, Neoplasm - drug effects | Receptors, Growth Factor - metabolism
Journal Article
Cancer Science, ISSN 1347-9032, 01/2008, Volume 99, Issue 1, pp. 14 - 22
In this study we explored the mechanisms of constitutive activation of c-Met in lung adenocarcinoma cell lines. First, we examined levels of c-Met and... 
Journal Article
Pediatric Neurology, ISSN 0887-8994, 1994, Volume 11, Issue 2, pp. 96 - 96
Journal Article
サイトメトリーリサーチ, ISSN 0916-6920, 2002, Volume 12, Issue 1, pp. 39 - 48
Flow cytometric analysis is indespensable for identifying immunophenotypically hematopoietic cells. In such analysis, it is the most important issue how to... 
Flow cytometry | Leuko-GATETM | CD45/CD14 | SSC/FSC | Cytogram | Two-color gating | Gating
Journal Article
Japanese Journal of Cancer Research, ISSN 0910-5050, 05/2001, Volume 92, Issue 5, pp. 494 - 498
Journal Article
by MATSUSHIMA, Hisashi and FUJITA, Kimio and MORIYAMA, Nobuo and TAJIMA, Atsushi and ASO, Yoshio and Matsuta, Morimasa and Matsuta, Mayumi and Weier, Heinz-Ulrich and Pinkel, Daniel and Mehraein, Yasmin and Gray, Joe and Mizuhira, Vinci and Hasegawa, Hiroshi and Notoya, Mitsuru and MORIGUCHI, Keiichi and HIRAI, Kei-Ichi and MORITA, Takashi and USUDA, Nobuteru and HANAI, Toru and KONG, Yongli and NAGATA, Testuji and MURAKOSHI, M and INADA, R and TAGAWA, M and SHOJI, M and SUZUKI, M and WATANABE, K and NAGAMOTO, Noriyoshi and TAKAGI, Katsumasa and IYAMA, Ken-ichi and KITAOKA, Mitsuhiko and Usuku, Gentarou and NAGASE, Yasushi and MORIYAMA, Nobuo and TAJIMA, Atsushi and HOSAKA, Yoshio and HIGASHIHARA, Eiji and ASO, Yoshio and NAGASHIMA, Toshiko and TANABE, Hitoshi and FUJII, Sachiko and GOTOHDA, Yuko and FUJIOKA, Yasunori and NAGASHIMA, Kazuo and NISHIDA, Yoshinao and FUJIMOTO, Toyoshi and OGAWA, Kazuo and NISHIMOTO, Hiroshi and YAMADA, Gotaro and MIZUNO, Motowo and ENDOH, Hisashi and TSUJI, Takao and Nishimura, N and Nishimura, H and Karasawa, M and Kuroki, T and Suzuki, J and Tohyama, C and NOTOYA, Mitsuru and MIZUHIRA, Vinci and HASEGAWA, Hiroshi and NUMANO, Fujio and TSUKUDA, Toyohiro and KUROIWA, Tomoe and SUZUKI, Akio and AMANO, Jun and Tokuda, Y and Kubota, M and Tajima, T and Osamura, R.Y and OGUNI, Masami and MATSUI, Hiroshi and TAMURA, Haruko and SHINOHARA, Haruo and TANAKA, Osamu and Oguro, Keiji and Nakagura, Masahiko and Masuzawa, Toshio and OHTA, K and MINAGAWA, T and SUWA, T and MORIYAMA, N and ASO, Y and Ohtani, Haruo and Nagura, Hiroshi and Sasada, Reiko and Kozai, Yoshio and Ohtawara, Yoshihisa and Suzuki, Kazuo and Tajima, Atsushi and Kawabe, Kazuki and Aso, Yoshio and OKADA, Hiyoshi and TSUBURA, Airo and MORII, Sotokichi and NAKA, Yuji and KOMATSU, Yosuke and Liang, QIAN and AOYAGI, Masaru and HIRAKAWA, Kimiyoshi and ...
ACTA HISTOCHEMICA ET CYTOCHEMICA, ISSN 0044-5991, 1991, Volume 24, Issue 5, pp. 526 - 533
Journal Article